Enjoy Free Delivery when you spend £200 or more!
Introducing New Remedium Research Retatrutide 30mg Pen to you at £149 for a limited time only.
Shop Now

Adelphi Triple-X 30mg (30 Tablets)

£ 44.99

Adelphi Triple-X 30mg is a potent three-compound research oral blend containing Stanozolol 10mg, Oxymetholone 10mg, and Methandrostenolone 10mg. It is examined in laboratory environments for strength modelling, performance enhancement, and lean mass development simulations. For research use only.

Adelphi Triple-X 30mg (30 Tablets) is a high-performance research oral formulation combining three well-known anabolic research compounds:

  • Stanozolol – 10mg

  • Oxymetholone – 10mg

  • Methandrostenolone – 10mg

This blend provides a multi-pathway model for performance enhancement, strength progression, and metabolic adaptation, making it suitable for advanced laboratory simulations involving physical performance and physique-related modelling.

Compound Breakdown

Stanozolol (10mg)

Referenced in research for:

  • Increased neuromuscular efficiency

  • Reduced water retention and a “dry” muscular appearance

  • Enhanced strength and speed under controlled conditions

  • Non-aromatizing behaviour providing clean outcome modelling

Oxymetholone (10mg)

Known in studies for:

  • Powerful anabolic response profile

  • Significant increases in nitrogen retention

  • Rapid improvements in strength during short-term modelling

  • Cell volumisation under high-output performance studies

Methandrostenolone (10mg)

Frequently included in research involving:

  • Strong anabolic-androgenic response markers

  • Rapid strength and training-output improvements

  • Enhanced protein synthesis under controlled environments

The combination of all three creates a triple-action research platform, allowing scientists to study synergy, comparative pathways, and strength-based responses within one formulation.


Key Research Features

  • Triple-compound formulation for multi-pathway modelling

  • Rapid strength and performance response under structured conditions

  • Lean mass development and recomposition study potential

  • Enhanced nitrogen retention and protein synthesis indicators

  • Non-aromatizing and aromatizable compounds combined for varied outcome modelling

  • Suitable for short-duration, high-output research protocols


How to Use (Research Reference Only)

Laboratory literature commonly references:

  • 1 tablet daily
    Modelling frequency may vary depending on experimental objectives.

This is research context only — not usage advice.


Stacking (Research Context)

Adelphi Triple-X 30mg is often referenced in advanced performance-based research environments and may be studied alongside:

  • Anavar

  • Winstrol

  • Primobolan

  • Trenbolone

Stacking varies depending on study design and modelling variables.


Summary

Adelphi Triple-X 30mg (30 Tablets) is a potent triple-compound oral formulation designed for laboratory research requiring high-strength performance modelling, multi-pathway anabolic evaluation, and advanced lean mass or strength simulations. Its unique combination of Stanozolol, Oxymetholone, and Methandrostenolone makes it a versatile compound for performance and recomposition-focused research studies.


Research Disclaimer

For scientific and laboratory research use only.
Not intended for human use, medical treatment, or veterinary application.

0 reviews for Adelphi Triple-X 30mg (30 Tablets)

Be the first to review “Adelphi Triple-X 30mg (30 Tablets)”

Your email address will not be published. Required fields are marked *

Supportscreen tag